SO vs ZYME · P/E 22, rev $6.26B vs rev $76.3M
Southern Company (SO) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
SO currently screens at market cap $101.55B and trailing P/E 22.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the SO and ZYME stock pages for the full models.
Not investment advice.